Cancer Chemoprevention with Korean Angelica

Active Compounds, Pharmacokinetics, and Human Translational Considerations

Junxuan Lu, Jinhui Zhang, Li Li, Cheng Jiang, Chengguo Xing

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Angelica gigas Nakai (AGN) is a major medicinal herb used in Korea and several other Asian countries. Traditionally, its dried root has been used to treat anemia, pain, infection, and articular rheumatism, most often through boiling in water to prepare the dosage forms. AGN extract or AGN-containing herbal mixtures are sold in the USA and globally as dietary supplements for pain killing, memory enhancement, and post-menopausal symptom relief. Decursin (D) and its isomer decursinol angelate (DA) are the major chemicals in the alcoholic extracts of the root of AGN. The anti-cancer activity of AGN alcoholic extract has been established in a number of animal cancer models, including a transgenic model of prostate carcinogenesis. Cell culture structure-activity studies have uncovered distinct cellular and molecular effects of D and DA vs. their pyranocoumarin core decursinol (DOH) with respect to cancer cells and those associated with their microenvironment. Pharmacokinetic (PK) study by us and others in rodent models indicated that DOH is the major and rapid in vivo first pass liver metabolite of D and DA. Cognizant of metabolic differences among rodents and humans, we carried out a first-in-human PK study of D/DA to inform the translational relevance of efficacy and mechanism studies with rodent models. The combined use of rigorous animal tests and human PK studies can provide stronger scientific rationale to inform design and execution of translational studies to move AGN toward evidence-based herbal medicine.

Original languageEnglish (US)
Pages (from-to)373-381
Number of pages9
JournalCurrent Pharmacology Reports
Volume1
Issue number6
DOIs
StatePublished - Dec 1 2015

Fingerprint

Angelica
Pharmacokinetics
Chemoprevention
Rodentia
Neoplasms
Pyranocoumarins
Animals
Dietary supplements
Pain
Herbal Medicine
Evidence-Based Medicine
Dosage Forms
Medicinal Plants
Korea
Metabolites
Dietary Supplements
Rheumatic Diseases
Cell culture
Isomers
Liver

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this

@article{1efced9f16a648e0a11fd07924d30255,
title = "Cancer Chemoprevention with Korean Angelica: Active Compounds, Pharmacokinetics, and Human Translational Considerations",
abstract = "Angelica gigas Nakai (AGN) is a major medicinal herb used in Korea and several other Asian countries. Traditionally, its dried root has been used to treat anemia, pain, infection, and articular rheumatism, most often through boiling in water to prepare the dosage forms. AGN extract or AGN-containing herbal mixtures are sold in the USA and globally as dietary supplements for pain killing, memory enhancement, and post-menopausal symptom relief. Decursin (D) and its isomer decursinol angelate (DA) are the major chemicals in the alcoholic extracts of the root of AGN. The anti-cancer activity of AGN alcoholic extract has been established in a number of animal cancer models, including a transgenic model of prostate carcinogenesis. Cell culture structure-activity studies have uncovered distinct cellular and molecular effects of D and DA vs. their pyranocoumarin core decursinol (DOH) with respect to cancer cells and those associated with their microenvironment. Pharmacokinetic (PK) study by us and others in rodent models indicated that DOH is the major and rapid in vivo first pass liver metabolite of D and DA. Cognizant of metabolic differences among rodents and humans, we carried out a first-in-human PK study of D/DA to inform the translational relevance of efficacy and mechanism studies with rodent models. The combined use of rigorous animal tests and human PK studies can provide stronger scientific rationale to inform design and execution of translational studies to move AGN toward evidence-based herbal medicine.",
author = "Junxuan Lu and Jinhui Zhang and Li Li and Cheng Jiang and Chengguo Xing",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s40495-015-0033-y",
language = "English (US)",
volume = "1",
pages = "373--381",
journal = "Current Pharmacology Reports",
issn = "2198-641X",
publisher = "Springer International Publishing AG",
number = "6",

}

Cancer Chemoprevention with Korean Angelica : Active Compounds, Pharmacokinetics, and Human Translational Considerations. / Lu, Junxuan; Zhang, Jinhui; Li, Li; Jiang, Cheng; Xing, Chengguo.

In: Current Pharmacology Reports, Vol. 1, No. 6, 01.12.2015, p. 373-381.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cancer Chemoprevention with Korean Angelica

T2 - Active Compounds, Pharmacokinetics, and Human Translational Considerations

AU - Lu, Junxuan

AU - Zhang, Jinhui

AU - Li, Li

AU - Jiang, Cheng

AU - Xing, Chengguo

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Angelica gigas Nakai (AGN) is a major medicinal herb used in Korea and several other Asian countries. Traditionally, its dried root has been used to treat anemia, pain, infection, and articular rheumatism, most often through boiling in water to prepare the dosage forms. AGN extract or AGN-containing herbal mixtures are sold in the USA and globally as dietary supplements for pain killing, memory enhancement, and post-menopausal symptom relief. Decursin (D) and its isomer decursinol angelate (DA) are the major chemicals in the alcoholic extracts of the root of AGN. The anti-cancer activity of AGN alcoholic extract has been established in a number of animal cancer models, including a transgenic model of prostate carcinogenesis. Cell culture structure-activity studies have uncovered distinct cellular and molecular effects of D and DA vs. their pyranocoumarin core decursinol (DOH) with respect to cancer cells and those associated with their microenvironment. Pharmacokinetic (PK) study by us and others in rodent models indicated that DOH is the major and rapid in vivo first pass liver metabolite of D and DA. Cognizant of metabolic differences among rodents and humans, we carried out a first-in-human PK study of D/DA to inform the translational relevance of efficacy and mechanism studies with rodent models. The combined use of rigorous animal tests and human PK studies can provide stronger scientific rationale to inform design and execution of translational studies to move AGN toward evidence-based herbal medicine.

AB - Angelica gigas Nakai (AGN) is a major medicinal herb used in Korea and several other Asian countries. Traditionally, its dried root has been used to treat anemia, pain, infection, and articular rheumatism, most often through boiling in water to prepare the dosage forms. AGN extract or AGN-containing herbal mixtures are sold in the USA and globally as dietary supplements for pain killing, memory enhancement, and post-menopausal symptom relief. Decursin (D) and its isomer decursinol angelate (DA) are the major chemicals in the alcoholic extracts of the root of AGN. The anti-cancer activity of AGN alcoholic extract has been established in a number of animal cancer models, including a transgenic model of prostate carcinogenesis. Cell culture structure-activity studies have uncovered distinct cellular and molecular effects of D and DA vs. their pyranocoumarin core decursinol (DOH) with respect to cancer cells and those associated with their microenvironment. Pharmacokinetic (PK) study by us and others in rodent models indicated that DOH is the major and rapid in vivo first pass liver metabolite of D and DA. Cognizant of metabolic differences among rodents and humans, we carried out a first-in-human PK study of D/DA to inform the translational relevance of efficacy and mechanism studies with rodent models. The combined use of rigorous animal tests and human PK studies can provide stronger scientific rationale to inform design and execution of translational studies to move AGN toward evidence-based herbal medicine.

UR - http://www.scopus.com/inward/record.url?scp=85015579766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015579766&partnerID=8YFLogxK

U2 - 10.1007/s40495-015-0033-y

DO - 10.1007/s40495-015-0033-y

M3 - Review article

VL - 1

SP - 373

EP - 381

JO - Current Pharmacology Reports

JF - Current Pharmacology Reports

SN - 2198-641X

IS - 6

ER -